Biohit Oyj

Board/Management Information • Jan 31, 2019

Disclosure 367945

Biohit Oyj - Changes board/management/auditors

Business Development Director Lea Paloheimo will retire from Biohit Oyj

Biohit Oyj 31.01.2019 at 12:00 local time (EST)

Biohit’s management team member Business Development Director Lea Paloheimo will retire as planned 31st of January 2019. Lea Paloheimo has been employed by Biohit since 2001.

”I would like to thank Lea for the excellent work during these years at Biohit in multiple different roles”, says Semi Korpela, President and CEO of Biohit.

Additional information:

CEO Semi Korpela, Biohit Oyj

tel. +358 9 773 861

investor.relations@biohit.fi

www.biohithealthcare.com

Biohit Oyj in brief

Biohit Oyj is a globally operating Finnish biotechnology company. Biohit’s mission ‘Innovating for Health’ means that we provide innovative products and services to promote research and early diagnostics. Biohit is headquartered in Helsinki and has subsidiaries in Italy and the UK. Biohit’s B series shares (BIOBV) are quoted on NASDAQ OMX Helsinki under Small cap/Healthcare. www.biohithealthcare.com